# The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, Paragraph 4ZB: Objection to and termination of hub and spoke arrangements


(1) NHS England may at any time request from D (as defined in paragraph 4ZA(3)) information relating to hub and spoke arrangements that is relevant to the termination criteria (whether or not the arrangements have commenced), and if NHS England makes such a request, D must supply the requested information to NHS England promptly.
(2) For the purposes of this paragraph, the termination criteria are—
(a) the hub and spoke arrangements do not have the features required by paragraph 4ZA(7), including where they have had them but they have lapsed;
(b) the hub and spoke arrangements have the features required by paragraph 4ZA(7) but there has been a breach of those requirements;
(c) the hub and spoke arrangements put the safety of any persons to whom D provides pharmaceutical services at serious risk;
(d) the hub and spoke arrangements put NHS England at risk of material financial loss;
(e) the hub and spoke arrangements have led to D repeatedly breaching D’s terms of service, or to D breaching its terms of service in circumstances where D is likely to continue to do so repeatedly;
(f) P’s (as defined in paragraph 4ZA(4)) fitness to carry out core dispensing functions is impaired; or
(g) in the opinion of NHS England, there are reasonable grounds for believing one or more of the termination criteria in paragraphs (a) to (f) are established.
(3) NHS England may, after the commencement of hub and spoke arrangements, issue a notice of objection to the arrangements, based on one or more of the termination criteria, and if it does so—
(a) those arrangements become invalid on the termination date specified in the notice of objection; and
(b) D must discontinue the arrangements on or by the date specified in the notice for their termination.
(4) NHS England may withdraw a notice of objection issued under sub-paragraph (3), which has the effect of the arrangements to which the notice related no longer being invalid.
(5) NHS England must, in a notice of objection, give its reasons for issuing the notice.
(6) Subject to sub-paragraph (7), before issuing a notice of objection, NHS England must make every reasonable effort to communicate and co-operate with D with a view to resolving the matter without the notice being issued.
(7) Sub-paragraph (6) does not apply where NHS England is satisfied—
(a) its concerns relate to a matter that has already been the subject of dispute resolution between NHS England and D and there are no new issues of substance to delay issuing the notice; or
(b) that it is appropriate to proceed immediately to issuing a notice—
(i) to protect the safety of any persons to whom D may provide pharmaceutical services, or
(ii) to protect NHS England from material financial loss.
(8) After issuing a notice of objection, unless—
(a) it was delayed by virtue of sub-paragraph (6); or
(b) NHS England is satisfied its concerns related to a matter that has already been the subject of dispute resolution between NHS England and D and there are no new issues of substance to be resolved,
NHS England must, where requested to do so by D, make every reasonable effort to communicate and co-operate with D with a view to resolving the matter in a manner that may lead to the notice of objection being withdrawn.

---
Source: https://www.legislation.gov.uk/uksi/2013/349/schedule/6/paragraph/4ZB (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-6/paragraph-4ZB
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

